Skip to content

ArteMedicale: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ArteMedicale

BE 0749.600.558
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€54,098
2024 · €157,749-€103,651
Equity
€54,398
2024 · €233,875-€179,478
Cash
€276,649
2024 · €239,627+€37,022
Balance sheet total
€385,815
2024 · €420,231-€34,416

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€91,533

    down €91,533 (-60.0%), from €152,632 to €61,099

    of which Other tangible fixed assets: -€91,944

  • Cash +€37,022

    up €37,022 (+15.4%), from €239,627 to €276,649

    mainly Other debts (+€165,853) and Investment in fixed assets (net) (+€88,344)

  • Receivables within one year +€19,833

    up €19,833 (+74.8%), from €26,523 to €46,356

    of which Other amounts receivable: +€18,762

Equity and liabilities
  • Reserves -€179,478

    down €179,478 (-76.8%), from €233,575 to €54,098

  • Other debts +€165,853

    up €165,853 (+109.0%), from €152,177 to €318,030

  • Tax, wage and social debts -€22,128

    down €22,128 (-68.2%), from €32,439 to €10,311

Income statement
  • Financial charges +€37,637

    up €37,637 (+346.8%), from €10,854 to €48,490

  • Taxes -€34,487

    down €34,487 (-64.6%), from €53,406 to €18,919

  • Gross operating margin -€17,514

    down €17,514 (-7.7%), from €228,883 to €211,369

  • Depreciation -€5,164

    down €5,164 (-61.8%), from €8,352 to €3,188

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €157,749
Gross operating margin -€17,514
Depreciation +€5,164
Other operating charges -€450
Other operating items -€86,979
Financial income -€722
Financial charges -€37,637
Taxes +€34,487
Result 2025 €54,098

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€182,253
Investment +€88,344
Financing -€233,575
Cash 2024 €239,627
Net result for the year +€54,098
Depreciation +€3,188
Receivables within one year -€19,833
Smaller working-capital items -€274
Trade debts +€1,349
Tax, wage and social debts -€22,128
Other debts +€165,853
Investment in fixed assets (net) +€88,344
Contributions, distributions and other -€233,575
Cash 2025 €276,649
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €420,231 €385,815 -€34,416 -8.2%
Fixed assets 21/28 €152,632 €61,099 -€91,533 -60.0%
Tangible fixed assets 22/27 €152,632 €61,099 -€91,533 -60.0%
Furniture and vehicles 24 €6,978 €7,389 +€411 +5.9%
Other tangible fixed assets 26 €145,654 €53,710 -€91,944 -63.1%
Current assets 29/58 €267,599 €324,716 +€57,117 +21.3%
Amounts receivable within one year 40/41 €26,523 €46,356 +€19,833 +74.8%
Trade receivables 40 €26,523 €27,594 +€1,071 +4.0%
Other amounts receivable 41 - €18,762 +€18,762
Cash at bank and in hand 54/58 €239,627 €276,649 +€37,022 +15.4%
Deferred charges and accrued income 490/1 €1,450 €1,711 +€261 +18.0%
Total equity and liabilities 10/49 €420,231 €385,815 -€34,416 -8.2%
Equity 10/15 €233,875 €54,398 -€179,478 -76.7%
Contributions 10/11 €300 €300 = 0.0%
Reserves 13 €233,575 €54,098 -€179,478 -76.8%
Distributable reserves 133 €233,575 €54,098 -€179,478 -76.8%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €186,356 €331,417 +€145,061 +77.8%
Amounts payable within one year 42/48 €186,343 €331,417 +€145,074 +77.9%
Trade debts 44 €1,727 €3,076 +€1,349 +78.1%
Suppliers 440/4 €1,727 €3,076 +€1,349 +78.1%
Taxes, remuneration and social security 45 €32,439 €10,311 -€22,128 -68.2%
Taxes 450/3 €32,439 €10,311 -€22,128 -68.2%
Other amounts payable 47/48 €152,177 €318,030 +€165,853 +109.0%
Accrued charges and deferred income 492/3 €13 €0 -€13 -100.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,352 €3,188 -€5,164 -61.8%
Other operating charges 640/8 €735 €1,186 +€450 +61.3%
Non-recurring operating charges 66A - €86,979 +€86,979
Gross operating margin 9900 €228,883 €211,369 -€17,514 -7.7%
Operating profit (loss) 9901 €219,796 €120,016 -€99,780 -45.4%
Financial income 75/76B €2,213 €1,491 -€722 -32.6%
Recurring financial income 75 €2,213 €1,491 -€722 -32.6%
Financial charges 65/66B €10,854 €48,490 +€37,637 +346.8%
Recurring financial charges 65 €10,854 €48,490 +€37,637 +346.8%
Profit (loss) for the period before taxes 9903 €211,155 €73,017 -€138,138 -65.4%
Income taxes 67/77 €53,406 €18,919 -€34,487 -64.6%
Profit (loss) for the period 9904 €157,749 €54,098 -€103,651 -65.7%
Profit (loss) for the period to be appropriated 9905 €157,749 €54,098 -€103,651 -65.7%

Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.